Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-08-30

FDA Approved: FIRAZYR — Supplemental Application (Takeda Pharmaceuticals America, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Firazyr (icatibant acetate) from Takeda Pharmaceuticals America, Inc., resulting in changes to the drug's existing a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Firazyr (icatibant)

Snippet

SUPPL AP for FIRAZYR (ICATIBANT ACETATE)